Claudio Hidalgo Cantabrana, CEO at Microviable Therapeutics, and our CBO, Rafael Permuy, will be attending Bio€quity Europe event in San Sebastián (Spain) from May 12th to 14th and May 21, 22 (virtual).

On Tuesday 14th May, Claudio Hidalgo will be giving a corporate presentation (Room 9 from 12:15 to 12:27) in front of international investors to showcase Microviable´s activity and next steps towards bringing our microbiome-derived biological drugs into clinical trials.

Microviable Team joins BioCentury, EBD Group, and Regional Host Committee Chair Ysios Capital in one of the world’s culinary capitals for a destination event designed for CEOs, investors, and decision-makers across the global biopharma ecosystem.

Meet with us at the event! We are thrilled to invite you to explore potential strategic partnership opportunities. Our mission is to develop novel biological drugs and personalized therapies to address unmet challenges in human diseases providing innovative solutions based on the microbiota.

Contact Claudio Hidalgo Cantabrana, PhD:

Contact Rafael M. Permuy, MBA: